IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i9p5379-d804649.html
   My bibliography  Save this article

Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App

Author

Listed:
  • Massimo Radin

    (Center of Excellence for Nephrologic, Rheumatologic and Rare Diseases, CMID-Nephrology and Dialysis, Department of Clinical and Biological Sciences, Ospedale San Giovanni Bosco, 10154 Turin, Italy
    Department of Clinical and Biological Sciences, School of Specialization of Clinical Pathology, 20122 Turin, Italy)

  • Marta Arbrile

    (Center of Excellence for Nephrologic, Rheumatologic and Rare Diseases, CMID-Nephrology and Dialysis, Department of Clinical and Biological Sciences, Ospedale San Giovanni Bosco, 10154 Turin, Italy
    Department of Clinical and Biological Sciences, School of Specialization of Clinical Pathology, 20122 Turin, Italy)

  • Irene Cecchi

    (Center of Excellence for Nephrologic, Rheumatologic and Rare Diseases, CMID-Nephrology and Dialysis, Department of Clinical and Biological Sciences, Ospedale San Giovanni Bosco, 10154 Turin, Italy
    Department of Clinical and Biological Sciences, School of Specialization of Clinical Pathology, 20122 Turin, Italy)

  • Pierluigi Di Nunzio

    (DNDG s.r.l., 10100 Turin, Italy)

  • Nicola Buccarano

    (DNDG s.r.l., 10100 Turin, Italy)

  • Federico Di Gregorio

    (DNDG s.r.l., 10100 Turin, Italy)

  • Valeria Milone

    (Pharmacy Department, S. Giovanni Bosco Hospital, 10154 Turin, Italy)

  • Sara Osella

    (Pharmacy Department, S. Giovanni Bosco Hospital, 10154 Turin, Italy)

  • Paola Crosasso

    (Pharmacy Department, S. Giovanni Bosco Hospital, 10154 Turin, Italy)

  • Marika Denise Favuzzi

    (Department of Clinical and Biological Sciences, School of Specialization of Clinical Pathology, 20122 Turin, Italy)

  • Alice Barinotti

    (Department of Clinical and Biological Sciences, School of Specialization of Clinical Pathology, 20122 Turin, Italy)

  • Simone Baldovino

    (Center of Excellence for Nephrologic, Rheumatologic and Rare Diseases, CMID-Nephrology and Dialysis, Department of Clinical and Biological Sciences, Ospedale San Giovanni Bosco, 10154 Turin, Italy
    Department of Clinical and Biological Sciences, School of Specialization of Clinical Pathology, 20122 Turin, Italy)

  • Elisa Menegatti

    (Department of Clinical and Biological Sciences, School of Specialization of Clinical Pathology, 20122 Turin, Italy)

  • Daniela Rossi

    (Center of Excellence for Nephrologic, Rheumatologic and Rare Diseases, CMID-Nephrology and Dialysis, Department of Clinical and Biological Sciences, Ospedale San Giovanni Bosco, 10154 Turin, Italy)

  • Savino Sciascia

    (Center of Excellence for Nephrologic, Rheumatologic and Rare Diseases, CMID-Nephrology and Dialysis, Department of Clinical and Biological Sciences, Ospedale San Giovanni Bosco, 10154 Turin, Italy
    Department of Clinical and Biological Sciences, School of Specialization of Clinical Pathology, 20122 Turin, Italy
    These authors contributed equally to this work.)

  • Dario Roccatello

    (Center of Excellence for Nephrologic, Rheumatologic and Rare Diseases, CMID-Nephrology and Dialysis, Department of Clinical and Biological Sciences, Ospedale San Giovanni Bosco, 10154 Turin, Italy
    These authors contributed equally to this work.)

Abstract

To support the management of rheumatoid arthritis (RA) patients treated with tofacitinib, we designed the TuTOR (tailoring tofacitinib oral therapy in rheumatoid arthritis) mobile app. The impact of the app on medical adherence was evaluated using a crossover design alternating a paper-diary and the TuTOR App. Twenty patients with RA (mean age at inclusion, 59 ± 13 years) were included in the study. A statistically significant decrease in DAS28 was observed since the first month of therapy (mean DAS28 at baseline, 3.9 ± 1 vs. 1° month 3.1 ± 1, p = 0.0016). Similarly, the numerical rating scale (NRS) of perceived activity of disease and subjective fatigue progressively decreased. No differences were reported in DAS28 or NRS between the TuTOR app and the paper-diary groups. A significant decrease was observed in HAQ during the follow-up (baseline 1.38 ± 1.11 vs. six months 0.83 ± 0.9; p = 0.01). When filling out the self-reporting questionnaires, most of the patients (82%) preferred the TuTOR App helping them to remember to take the pills. Furthermore, 82% of patients used the app regularly (vs. 53% for the paper diary). Three patients suspended tofacitinib due to gastrointestinal intolerance. Both digital and paper devices can help maximize adherence to therapy; however, the TuTOR app was preferred by the patients for its simplicity and immediacy.

Suggested Citation

  • Massimo Radin & Marta Arbrile & Irene Cecchi & Pierluigi Di Nunzio & Nicola Buccarano & Federico Di Gregorio & Valeria Milone & Sara Osella & Paola Crosasso & Marika Denise Favuzzi & Alice Barinotti &, 2022. "Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App," IJERPH, MDPI, vol. 19(9), pages 1-11, April.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:9:p:5379-:d:804649
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/9/5379/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/9/5379/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Savino Sciascia & Massimo Radin & Irene Cecchi & Pierluigi Di Nunzio & Nicola Buccarano & Federico Di Gregorio & Milone Valeria & Sara Osella & Paola Crosasso & Marika Denise Favuzzi & Elena Rubini & , 2020. "Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTORApp—A Usability Study," IJERPH, MDPI, vol. 17(10), pages 1-9, May.
    2. Till Uhlig & Rikke Moe & Tore Kvien, 2014. "The Burden of Disease in Rheumatoid Arthritis," PharmacoEconomics, Springer, vol. 32(9), pages 841-851, September.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Xavier Janssens & Saskia Decuman & Filip De Keyser & Belgian Rheumatoid Arthritis Disability Assessment study group, 2016. "Comparison of the Belgian Rheumatoid Arthritis Disability Assessment and Health Assessment Questionnaires as Tools to Predict the Need for Support Measures in Patients with Rheumatoid Arthritis," PLOS ONE, Public Library of Science, vol. 11(1), pages 1-11, January.
    2. Monika Laugesen & Mette Rasmussen & Robin Christensen & Hanne Tønnesen & Henning Bliddal, 2022. "Smoking Cessation Rates among Patients with Rheumatoid Arthritis and Osteoarthritis Following the ‘Gold Standard Programme’ (GSP): A Prospective Analysis from the Danish Smoking Cessation Database," IJERPH, MDPI, vol. 19(10), pages 1-14, May.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:9:p:5379-:d:804649. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.